DELETERIOUS EFFECTS OF HIGHER BODY MASS INDEX ON SUBJECTIVE AND OBJECTIVE MEASURES OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER SURVIVORS

CONTEXT: Recent albeit limited evidence suggests that body mass index (BMI) may be a modifiable risk factor to reduce the deleterious effects of chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors. OBJECTIVES: Purpose was to evaluate for differences in demographic, clinical, pain,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Pain Symptom Manage
Auteurs principaux: Petrovchich, Iva, Kober, Kord M., Wagner, Laura, Paul, Steven M., Abrams, Gary, Chesney, Margaret A., Topp, Kimberly, Smoot, Betty, Schumacher, Mark, Conley, Yvette P., Hammer, Marilyn, Levine, Jon D., Miaskowski, Christine
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6679783/
https://ncbi.nlm.nih.gov/pubmed/31047960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpainsymman.2019.04.029
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires